Project documents | Sirukumab for previously treated moderate to severe active rheumatoid arthritis (ID1002) | Guidance | NICE

Documents

Documents created during the development process.

Invitation to participate

Final matrix (PDF 255 KB)

Published:

28 July 2017
Final scope (MSWord 80 KB)

Published:

28 July 2017
NICE's response to comments on the draft scope and provisional matrix (PDF 321 KB)

Published:

28 July 2017

Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators

Draft scope pre referral (PDF 282 KB)

Published:

23 June 2017
Draft matrix pre referral (PDF 255 KB)

Published:

23 June 2017